Translating scientific discovery into therapeutic innovation is a long and arduous process requiring a multitude of special capabilities and creative input from many scientific disciplines.  Tyligand Bioscience has established collaborations with several leading institutions and technology companies in areas of target biology, medicinal chemistry, genomic and pharmacological research.  As our pipeline of molecules advance toward clinical development, we will continue to build and nurture partnerships with scientific excellence and complementary capabilities, and strive to become the partner of choice.